Jinhushen Biological Medical Science and Technology, a China-incorporated company that is in the business of technical research and development of biological and chemical products, agreed to acquire a 67% stake in TIANJIN Zhong Xin Pharmaceutical Group, a cardiovascular and respiratory medicines provider. Financial terms were not disclosed.